Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 355

1.

Nox2 NADPH oxidase is dispensable for platelet activation or arterial thrombosis in mice.

Sonkar VK, Kumar R, Jensen M, Wagner BA, Sharathkumar AA, Miller FJ Jr, Fasano M, Lentz SR, Buettner GR, Dayal S.

Blood Adv. 2019 Apr 23;3(8):1272-1284. doi: 10.1182/bloodadvances.2018025569.

2.

Delivery of Cell-Specific Aptamers to the Arterial Wall with an Occlusion Perfusion Catheter.

Udofot O, Lin LH, Thiel WH, Erwin M, Turner E, Miller FJ Jr, Giangrande PH, Yazdani SK.

Mol Ther Nucleic Acids. 2019 Jun 7;16:360-366. doi: 10.1016/j.omtn.2019.03.005. Epub 2019 Mar 23.

3.

RNA inhibitors of nuclear proteins responsible for multiple organ dysfunction syndrome.

Urak KT, Blanco GN, Shubham S, Lin LH, Dassie JP, Thiel WH, Chen Y, Sonkar VK, Lei B, Murthy S, Gutierrez WR, Wilson ME, Stiber JA, Klesney-Tait J, Dayal S, Miller FJ Jr, Giangrande PH.

Nat Commun. 2019 Jan 10;10(1):116. doi: 10.1038/s41467-018-08030-y.

4.

Redox Activation of Nox1 (NADPH Oxidase 1) Involves an Intermolecular Disulfide Bond Between Protein Disulfide Isomerase and p47phox in Vascular Smooth Muscle Cells.

Gimenez M, Veríssimo-Filho S, Wittig I, Schickling BM, Hahner F, Schürmann C, Netto LES, Rosa JC, Brandes RP, Sartoretto S, De Lucca Camargo L, Abdulkader F, Miller FJ Jr, Lopes LR.

Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):224-236. doi: 10.1161/ATVBAHA.118.311038.

PMID:
30580571
5.

Drebrin regulates angiotensin II-induced aortic remodelling.

Zhang L, Wu JH, Huang TQ, Nepliouev I, Brian L, Zhang Z, Wertman V, Rudemiller NP, McMahon TJ, Shenoy SK, Miller FJ, Crowley SD, Freedman NJ, Stiber JA.

Cardiovasc Res. 2018 Nov 1;114(13):1806-1815. doi: 10.1093/cvr/cvy151.

PMID:
29931051
6.

An updated analysis of respiratory tract cells at risk for formaldehyde carcinogenesis.

Miller FJ, Conolly RB, Kimbell JS.

Inhal Toxicol. 2017 Oct - Dec;29(12-14):586-597. doi: 10.1080/08958378.2018.1430191. Epub 2018 Feb 6.

PMID:
29405084
7.

Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function.

Leisegang MS, Fork C, Josipovic I, Richter FM, Preussner J, Hu J, Miller MJ, Epah J, Hofmann P, Günther S, Moll F, Valasarajan C, Heidler J, Ponomareva Y, Freiman TM, Maegdefessel L, Plate KH, Mittelbronn M, Uchida S, Künne C, Stellos K, Schermuly RT, Weissmann N, Devraj K, Wittig I, Boon RA, Dimmeler S, Pullamsetti SS, Looso M, Miller FJ Jr, Brandes RP.

Circulation. 2017 Jul 4;136(1):65-79. doi: 10.1161/CIRCULATIONAHA.116.026991. Epub 2017 Mar 28.

8.

Smooth Muscle Cell-targeted RNA Aptamer Inhibits Neointimal Formation.

Thiel WH, Esposito CL, Dickey DD, Dassie JP, Long ME, Adam J, Streeter J, Schickling B, Takapoo M, Flenker KS, Klesney-Tait J, Franciscis Vd, Miller FJ Jr, Giangrande PH.

Mol Ther. 2016 Apr;24(4):779-87. doi: 10.1038/mt.2015.235. Epub 2016 Jan 6.

9.

A case of spontaneous bile leak.

Peng C, Chubb D, Thomson BNK, Miller FJ.

ANZ J Surg. 2018 May;88(5):E458-E459. doi: 10.1111/ans.13409. Epub 2015 Dec 17. No abstract available.

PMID:
26678847
10.

Nox1 in cardiovascular diseases: regulation and pathophysiology.

Gimenez M, Schickling BM, Lopes LR, Miller FJ Jr.

Clin Sci (Lond). 2016 Feb;130(3):151-65. doi: 10.1042/CS20150404. Review.

PMID:
26678171
11.

Nox4 NADPH oxidase: emerging from the veil of darkness.

Miller FJ Jr.

Eur Heart J. 2015 Dec 21;36(48):3457-9. doi: 10.1093/eurheartj/ehv518. Epub 2015 Oct 1. No abstract available.

PMID:
26429798
12.

Chemiluminescence and the Nox1-Nox2-Nox4 Triple Knockout.

Pagano PJ, Griendling KK, Miller FJ, Laurindo FR, Touyz RM.

Antioxid Redox Signal. 2015 Nov 20;23(15):1246-7. doi: 10.1089/ars.2015.6382. Epub 2015 Jul 14. No abstract available.

PMID:
26054248
13.

Waiting for definitive care: An analysis of elapsed time from decision to surgery or transfer in a rural centre.

Dobson H, Ranasinghe WK, Hong MK, Bray LN, Sathveegarajah M, Vally F, Miller FJ.

Aust J Rural Health. 2015 Jun;23(3):155-60. doi: 10.1111/ajr.12160. Epub 2015 Apr 30.

PMID:
25929462
14.

In memoriam Donald E. Gardner, PhD, ATS (1931-2014).

Naas LA, Graham JA, Holsapple MP, Miller FJ, Selgrade MJ.

J Immunotoxicol. 2015 Apr-Jun;12(2):104-5. doi: 10.3109/1547691X.2014.994285. Epub 2014 Dec 26. No abstract available.

PMID:
25541221
15.

Role of NADPH oxidase and xanthine oxidase in mediating inducible VT/VF and triggered activity in a canine model of myocardial ischemia.

Martins JB, Chaudhary AK, Jiang S, Kwofie M, Mackie P, Miller FJ.

Int J Mol Sci. 2014 Nov 4;15(11):20079-100. doi: 10.3390/ijms151120079.

16.

Cell-internalization SELEX: method for identifying cell-internalizing RNA aptamers for delivering siRNAs to target cells.

Thiel WH, Thiel KW, Flenker KS, Bair T, Dupuy AJ, McNamara JO 2nd, Miller FJ, Giangrande PH.

Methods Mol Biol. 2015;1218:187-99. doi: 10.1007/978-1-4939-1538-5_11.

17.

Phosphorylation of Nox1 regulates association with NoxA1 activation domain.

Streeter J, Schickling BM, Jiang S, Stanic B, Thiel WH, Gakhar L, Houtman JC, Miller FJ Jr.

Circ Res. 2014 Nov 7;115(11):911-8. doi: 10.1161/CIRCRESAHA.115.304267. Epub 2014 Sep 16.

18.

Canonical Wnt signaling induces vascular endothelial dysfunction via p66Shc-regulated reactive oxygen species.

Vikram A, Kim YR, Kumar S, Naqvi A, Hoffman TA, Kumar A, Miller FJ Jr, Kim CS, Irani K.

Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2301-9. doi: 10.1161/ATVBAHA.114.304338. Epub 2014 Aug 21.

19.

Drs. Chan et al respond.

Chan MG, Miller FJ, Valji K, Kuo MD.

J Vasc Interv Radiol. 2014 Aug;25(8):1315-6. doi: 10.1016/j.jvir.2014.04.006. No abstract available.

PMID:
25085071
20.

Respiratory tract lung geometry and dosimetry model for male Sprague-Dawley rats.

Miller FJ, Asgharian B, Schroeter JD, Price O, Corley RA, Einstein DR, Jacob RE, Cox TC, Kabilan S, Bentley T.

Inhal Toxicol. 2014 Aug;26(9):524-44. doi: 10.3109/08958378.2014.925991.

PMID:
25055841
21.

Endothelial dysfunction in chronic inflammatory diseases.

Steyers CM 3rd, Miller FJ Jr.

Int J Mol Sci. 2014 Jun 25;15(7):11324-49. doi: 10.3390/ijms150711324. Review.

22.

Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques.

Xu S, Chamseddine AH, Carrell S, Miller FJ Jr.

Redox Biol. 2014 Apr 15;2:642-50. doi: 10.1016/j.redox.2014.04.004. eCollection 2014.

23.

Oxidative stress in cardiovascular disease.

Csányi G, Miller FJ Jr.

Int J Mol Sci. 2014 Apr 9;15(4):6002-8. doi: 10.3390/ijms15046002.

24.

Nox1 NADPH oxidase is necessary for late but not early myocardial ischaemic preconditioning.

Jiang S, Streeter J, Schickling BM, Zimmerman K, Weiss RM, Miller FJ Jr.

Cardiovasc Res. 2014 Apr 1;102(1):79-87. doi: 10.1093/cvr/cvu027. Epub 2014 Feb 5.

25.

Estimating lung burdens based on individual particle density estimated from scanning electron microscopy and cascade impactor samples.

Miller FJ, Kaczmar SW, Danzeisen R, Moss OR.

Inhal Toxicol. 2013 Dec;25(14):813-27. doi: 10.3109/08958378.2013.850562.

PMID:
24304308
26.

Evaluating patency rates of an ultralow-porosity expanded polytetrafluoroethylene covered stent in the treatment of venous stenosis in arteriovenous dialysis circuits.

Chan MG, Miller FJ, Valji K, Bansal A, Kuo MD.

J Vasc Interv Radiol. 2014 Feb;25(2):183-9. doi: 10.1016/j.jvir.2013.10.006. Epub 2013 Nov 25.

PMID:
24286940
27.

The epidermal growth factor receptor and its ligands in cardiovascular disease.

Makki N, Thiel KW, Miller FJ Jr.

Int J Mol Sci. 2013 Oct 15;14(10):20597-613. doi: 10.3390/ijms141020597. Review.

28.

Extracellular but not cytosolic superoxide dismutase protects against oxidant-mediated endothelial dysfunction.

Foresman EL, Miller FJ Jr.

Redox Biol. 2013 May 24;1:292-6. doi: 10.1016/j.redox.2013.04.003. eCollection 2013.

29.

Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis.

Kinkade K, Streeter J, Miller FJ.

Int J Mol Sci. 2013 Aug 19;14(8):17017-28. doi: 10.3390/ijms140817017.

30.

The multifunctional Ca²⁺/calmodulin-dependent kinase IIδ (CaMKIIδ) regulates arteriogenesis in a mouse model of flow-mediated remodeling.

Scott JA, Klutho PJ, El Accaoui R, Nguyen E, Venema AN, Xie L, Jiang S, Dibbern M, Scroggins S, Prasad AM, Luczak ED, Davis MK, Li W, Guan X, Backs J, Schlueter AJ, Weiss RM, Miller FJ, Anderson ME, Grumbach IM.

PLoS One. 2013 Aug 8;8(8):e71550. doi: 10.1371/journal.pone.0071550. eCollection 2013.

31.

NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitor erlotinib in head and neck cancer cells.

Sobhakumari A, Schickling BM, Love-Homan L, Raeburn A, Fletcher EV, Case AJ, Domann FE, Miller FJ Jr, Simons AL.

Toxicol Appl Pharmacol. 2013 Nov 1;272(3):736-45. doi: 10.1016/j.taap.2013.07.013. Epub 2013 Jul 31.

32.

CaMKII is essential for the proasthmatic effects of oxidation.

Sanders PN, Koval OM, Jaffer OA, Prasad AM, Businga TR, Scott JA, Hayden PJ, Luczak ED, Dickey DD, Allamargot C, Olivier AK, Meyerholz DK, Robison AJ, Winder DG, Blackwell TS, Dworski R, Sammut D, Wagner BA, Buettner GR, Pope RM, Miller FJ Jr, Dibbern ME, Haitchi HM, Mohler PJ, Howarth PH, Zabner J, Kline JN, Grumbach IM, Anderson ME.

Sci Transl Med. 2013 Jul 24;5(195):195ra97. doi: 10.1126/scitranslmed.3006135.

33.

Portal shunt scintigraphy (PSS) in the evaluation of patients suspected of hereditary hemorrhagic telangiectasia.

Nozawa A, Miller FJ, Rivandi AH, Hoh CK.

Clin Nucl Med. 2013 Sep;38(9):741-3. doi: 10.1097/RLU.0b013e31829a0164.

PMID:
23797221
34.

NOX2 protects against prolonged inflammation, lung injury, and mortality following systemic insults.

Whitmore LC, Hilkin BM, Goss KL, Wahle EM, Colaizy TT, Boggiatto PM, Varga SM, Miller FJ, Moreland JG.

J Innate Immun. 2013;5(6):565-80. doi: 10.1159/000347212. Epub 2013 Apr 27.

35.

Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis.

Dayal S, Wilson KM, Motto DG, Miller FJ Jr, Chauhan AK, Lentz SR.

Circulation. 2013 Mar 26;127(12):1308-16. doi: 10.1161/CIRCULATIONAHA.112.000966. Epub 2013 Feb 20.

36.

Development of a rhesus monkey lung geometry model and application to particle deposition in comparison to humans.

Asgharian B, Price O, McClellan G, Corley R, Einstein DR, Jacob RE, Harkema J, Carey SA, Schelegle E, Hyde D, Kimbell JS, Miller FJ.

Inhal Toxicol. 2012 Nov;24(13):869-99. doi: 10.3109/08958378.2012.725782.

37.

Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection.

Thiel WH, Bair T, Peek AS, Liu X, Dassie J, Stockdale KR, Behlke MA, Miller FJ Jr, Giangrande PH.

PLoS One. 2012;7(9):e43836. doi: 10.1371/journal.pone.0043836. Epub 2012 Sep 4.

38.

Reactive oxygen species: from health to disease.

Brieger K, Schiavone S, Miller FJ Jr, Krause KH.

Swiss Med Wkly. 2012 Aug 17;142:w13659. doi: 10.4414/smw.2012.13659. eCollection 2012. Review.

39.

Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis.

Stanic B, Pandey D, Fulton DJ, Miller FJ Jr.

Arterioscler Thromb Vasc Biol. 2012 Oct;32(10):2452-60. doi: 10.1161/ATVBAHA.112.256107. Epub 2012 Aug 9.

40.

Increased expression of Nox1 in neointimal smooth muscle cells promotes activation of matrix metalloproteinase-9.

Xu S, Shriver AS, Jagadeesha DK, Chamseddine AH, Szőcs K, Weintraub NL, Griendling KK, Bhalla RC, Miller FJ Jr.

J Vasc Res. 2012;49(3):242-8. doi: 10.1159/000332958. Epub 2012 Mar 15.

41.

β-Adrenergic receptor antagonists ameliorate myocyte T-tubule remodeling following myocardial infarction.

Chen B, Li Y, Jiang S, Xie YP, Guo A, Kutschke W, Zimmerman K, Weiss RM, Miller FJ, Anderson ME, Song LS.

FASEB J. 2012 Jun;26(6):2531-7. doi: 10.1096/fj.11-199505. Epub 2012 Feb 28.

42.

Opportunity nox: the future of NADPH oxidases as therapeutic targets in cardiovascular disease.

Streeter J, Thiel W, Brieger K, Miller FJ Jr.

Cardiovasc Ther. 2013 Jun;31(3):125-37. doi: 10.1111/j.1755-5922.2011.00310.x. Epub 2012 Jan 26. Review.

PMID:
22280098
43.

Individualized therapy of HHT driven by network analysis of metabolomic profiles.

Jamshidi N, Miller FJ, Mandel J, Evans T, Kuo MD.

BMC Syst Biol. 2011 Dec 20;5:200. doi: 10.1186/1752-0509-5-200.

44.

Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration.

Jagadeesha DK, Takapoo M, Banfi B, Bhalla RC, Miller FJ Jr.

Cardiovasc Res. 2012 Mar 1;93(3):406-13. doi: 10.1093/cvr/cvr308. Epub 2011 Nov 18.

45.

Statin therapy reduces growth of abdominal aortic aneurysms.

Karrowni W, Dughman S, Hajj GP, Miller FJ Jr.

J Investig Med. 2011 Dec;59(8):1239-43. doi: 10.2130/JIM.0b013e31823548e8.

46.

The fractions of respiratory tract cells at risk in formaldehyde carcinogenesis.

Miller FJ, Kimbell JS, Preston RJ, Overton JH, Gross EA, Conolly RB.

Inhal Toxicol. 2011 Oct;23(12):689-706. doi: 10.3109/08958378.2011.603190. Epub 2011 Sep 2.

PMID:
21888524
47.

Activation of NADPH oxidase 1 increases intracellular calcium and migration of smooth muscle cells.

Zimmerman MC, Takapoo M, Jagadeesha DK, Stanic B, Banfi B, Bhalla RC, Miller FJ Jr.

Hypertension. 2011 Sep;58(3):446-53. doi: 10.1161/HYPERTENSIONAHA.111.177006. Epub 2011 Aug 1.

48.

Glutathione peroxidase-deficient smooth muscle cells cause paracrine activation of normal smooth muscle cells via cyclophilin A.

Takapoo M, Chamseddine AH, Bhalla RC, Miller FJ Jr.

Vascul Pharmacol. 2011 Nov-Dec;55(5-6):143-8. doi: 10.1016/j.vph.2011.07.002. Epub 2011 Jul 12.

49.

Was the role of statins in slowing the progression of abdominal aortic aneurysms underestimated?

Karrowni W, Miller FJ Jr.

Am Heart J. 2011 May;161(5):e29; author reply e31. doi: 10.1016/j.ahj.2011.02.024. Epub 2011 Apr 7. No abstract available.

PMID:
21570503
50.

Erlotinib-mediated inhibition of EGFR signaling induces metabolic oxidative stress through NOX4.

Orcutt KP, Parsons AD, Sibenaller ZA, Scarbrough PM, Zhu Y, Sobhakumari A, Wilke WW, Kalen AL, Goswami P, Miller FJ Jr, Spitz DR, Simons AL.

Cancer Res. 2011 Jun 1;71(11):3932-40. doi: 10.1158/0008-5472.CAN-10-3425. Epub 2011 Apr 11.

Supplemental Content

Loading ...
Support Center